Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E33.13 EPS (ttm)1.30 Insider Own0.30% Shs Outstand1.46B Perf Week2.54%
Market Cap63.23B Forward P/E17.59 EPS next Y2.45 Insider Trans-0.99% Shs Float1.46B Perf Month12.12%
Income1.95B PEG3.56 EPS next Q0.58 Inst Own71.10% Short Float4.16% Perf Quarter-1.46%
Sales20.56B P/S3.08 EPS this Y53.50% Inst Trans0.30% Short Ratio5.28 Perf Half Y9.17%
Book/sh14.11 P/B3.06 EPS next Y11.60% ROA- Target Price47.64 Perf Year-13.61%
Cash/sh- P/C- EPS next 5Y9.31% ROE- 52W Range35.56 - 50.50 Perf YTD-2.08%
Dividend1.04 P/FCF- EPS past 5Y-10.30% ROI7.70% 52W High-14.51% Beta1.02
Dividend %2.41% Quick Ratio- Sales past 5Y-10.30% Gross Margin56.90% 52W Low21.39% ATR0.70
Employees74000 Current Ratio- Sales Q/Q3.20% Oper. Margin14.00% RSI (14)73.65 Volatility1.27% 1.58%
OptionableYes Debt/Eq- EPS Q/Q-22.50% Profit Margin11.10% Rel Volume0.89 Prev Close43.04
ShortableYes LT Debt/Eq- EarningsJul 20 BMO Payout66.50% Avg Volume11.54M Price43.17
Recom1.90 SMA206.55% SMA5010.59% SMA2005.96% Volume10,204,500 Change0.30%
Jul-21-16Reiterated Barclays Overweight $48 → $50
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-10-14Initiated Singular Research Sell $30
Dec-16-13Reiterated Deutsche Bank Hold $37 → $39
Jul-25-16 05:47AM  The Economy, Interest Rates, Earnings and the Markets
Jul-22-16 02:15PM  New Research Reports on NFLX, AXP, GM & Others
01:14PM  How Did Johnson & Johnsons Segments Perform in 2Q16?
10:21AM  Animal Spirits Have Returned
08:55AM  Did Hedge Funds Anticipate These M&A Deals? at Insider Monkey
07:29AM  R&D Investments, Product Launches Key to Abbotts 2Q Performance
07:29AM  Abbotts 2Q16 Earnings Propelled by Impressive Sales Growth
Jul-21-16 10:39AM  Abbott Laboratories :ABT-US: Earnings Analysis: Q2, 2016 By the Numbers : July 21, 2016
09:26AM  Abbott Labs (ABT) Stock Price Target Raised at Barclays
08:40AM  Opioid Addiction: What To Do When A Loved One Is Hooked, According To Science
08:00AM  How Abbvie's Humira Undercuts The Drug Industry Price Defense at Forbes
Jul-20-16 03:59PM  Pisani's market close: Big earnings today
03:33PM  Abbott (ABT) Beats on Earnings & Sales in Q2, Maintains View
03:06PM  [$$] Abbott Labs Profit Tops Views at The Wall Street Journal
02:52PM  US STOCKS-Microsoft propels Wall Street to new record highs Reuters
12:56PM  How Investors Reacted to The Latest Earnings Reports of These Companies at Insider Monkey
12:55PM  Abbott's Alere Deal Continues To Face Uncertainty
12:44PM  Edited Transcript of ABT earnings conference call or presentation 20-Jul-16 1:00pm GMT
10:40AM  [$$] St. Jude Medical Logs Double-Digit Sales Growth at The Wall Street Journal
09:31AM  St. Jude Medical Up Slightly as It Meets Estimates
09:26AM  Abbott sales beat on higher demand for medical devices
09:05AM  Abbott Labs (ABT) Stock Rising on Q2 Earnings Beat
09:00AM  Abbott Laboratories Earnings Call scheduled for 9:00 am ET today
08:32AM  Investors Greet Abbott Q2 Earnings Number
08:32AM  Abbott (ABT) Beats on Earnings & Sales in Q2
08:26AM  Morning Movers: Morgan Stanley Jumps on Earnings; Valeant Pharmaceuticals Climbs on Drug Approval at Barrons.com
08:02AM  Abbott tops Street 2Q forecasts
07:59AM  Abbott Quarterly Earnings Beat Expectations on Device Sales at Bloomberg
07:57AM  Abbott Labs reports 3.2 percent rise in sales
07:52AM  ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
07:45AM  Abbott Reports Second-Quarter 2016 Results PR Newswire
07:07AM  Q2 2016 Abbott Laboratories Earnings Release - Before Market Open
Jul-19-16 07:47PM  Will the Strong Dollar Hurt Abbott's Q2 Earnings? at Investopedia
03:35PM  Abbott Labs (ABT) Stock Falling Ahead of Q2 Earnings Report
02:45PM  St. Jude Medical (STJ) Stock Lower Ahead of Q2 Results
11:52AM  ETFs with exposure to Abbott Laboratories : July 19, 2016
10:06AM  Medical Stocks to Post Earnings This Week: ABT, BIIB, ALIOF
08:58AM  How to Profit From Abbott Labs
08:07AM  5 Big Medtech Stocks Investors Love Right Now -- but Should You Buy Them?
Jul-18-16 05:05PM  4 Big-Cap Medical Device Stocks Reporting Earnings This Week
01:53PM  What to Look for When Abbott Labs (ABT) Reports Q2 Earnings
12:07PM  4 Big-Cap Medical Device Stocks Reporting Earnings This Week
12:05PM  Abbott Laboratoriess Valuation before Its 2Q16 Results
10:06AM  What to Expect from Abbott Laboratoriess Earnings in 2Q16
09:37AM  Abbott Labs (ABT) Q2 Earnings: Will the Stock Surprise?
09:05AM  A Look at Johnson & Johnsons Valuation ahead of Its 2Q16 Results
08:30AM  Pharmaceutical Studies & Trials of Individual Cannabinoids Aim to Develop Cannabis Strains That Specifically Target Cancer Pain and Nausea CNW Group
Jul-16-16 02:04AM  Will Abbott Laboratories Beat Analysts Revenue Estimates in 2Q16?
Jul-15-16 05:11PM  The Reason Behind Alere Inc.'s Double-Digit Percentage Gain on Friday at Motley Fool
04:24PM  Alere Updates on 10K Filing, Reports Preliminary Q1 Figures
04:16PM  Alere Stock Upgraded As Canaccord Sees Abbott Buyout Closing
04:15PM  Analyst Sees No Major Concerns on Regulatory Front for Abbott-St. Jude Medical Deal
03:52PM  Why is Alere Inc. (ALR) up Today?
12:49PM  FDA Approves the Tecnis Symfony® Intraocular Lenses, the First and Only Extended Depth of Focus Lenses for People with Cataracts PR Newswire
Jul-14-16 08:41PM  Abbott Laboratories: Analyst Recommendations before 2Q16 Results
07:59PM  Alere Shares Soar After Releasing Partial 2015 Financial Results at Bloomberg
07:00PM  [$$] Alere Expects to Restate Financial Results at The Wall Street Journal
01:15PM  Health Canada approves Abbott's Absorb bioresorbable stent, the first fully dissolving heart stent CNW Group
10:40AM  Alere recall may further complicate fraught proposed merger with Abbott Labs at bizjournals.com
09:30AM  Zacks Industry Outlook Highlights: Johnson & Johnson, Smith & Nephew, Medtronic, Abbott Laboratories and St. Jude Medical
Jul-13-16 06:02PM  MedTech Tailwinds at a Glance: Which Stocks to Buy?
11:04AM  Can Thermo Fishers PPI Business System Continue to Drive Growth in 2016?
09:26AM  Heres Why Amazon, Tesla, and Three Other Stocks Are Trending Today at Insider Monkey
09:25AM  Pfizer (PFE) Gets FDA Nod for Label Expansion of Prevnar 13
09:06AM  How Will Abbott Labs (ABT) Stock Be Impacted by FTC Requests?
09:04AM  What Are Thermo Fishers Major Growth Catalysts in 2016?
08:50AM  Shoes Keep Dropping at Alere at Bloomberg
06:24AM  [$$] Abbott Labs Can Reap Upside Without Alere at Barrons.com
Jul-12-16 09:07PM  Medtronics Dividend Payment Rose Again: Must-Knows
08:08PM  How Innovation Is Driving Thermo Fisher Scientifics Growth
05:25PM  FTC seeks more info on Abbott-St. Jude deal Reuters
04:33PM  ABBOTT LABORATORIES Files SEC form 8-K, Other Events
04:23PM  [$$] Alere to Voluntarily Pull Blood-Monitoring Devices at The Wall Street Journal
12:11AM  Doctors Treat First Patient With Newly Approved Heart Stent at The Wall Street Journal
Jul-11-16 05:05PM  Aleres Device Recall Stirs More Questions About Abbott Deal at Bloomberg
02:59PM  Abbott Labs (ABT) Stock Gaining on Absorbable Stent Effectiveness
12:53PM  Stephanie Link's health care pick
09:23AM  Pfizer Reports Positive Data on Kidney Cancer Drug Sutent
Jul-09-16 01:00PM  The Best Way to Land a Job After an Internship at Fortune
Jul-08-16 01:16PM  Top 7 Research Reports for July 8, 2016
08:46AM  Why Is The FDA Approval Of Absorb Significant For Abbott? at Forbes
Jul-07-16 01:47PM  Spinoffs Are Outperforming Parent Companies
09:58AM  Abbott Labs' Absorb Stent Gets Regulatory Approval in U.S.
Jul-06-16 01:52PM  Trending Tickers: SWN, ABT, AAL, UAL, EW
01:05AM  FDA Approves Abbotts Absorbable Heart Stent at The Wall Street Journal
Jul-05-16 05:30PM  FDA approves first dissolving stent for US patients
01:10PM  Abbott deal for St. Jude spurs company split talk
12:35PM  Abbott Laboratories (ABT) Stock Slumps Despite FDA Approval
11:29AM  Abbott wins U.S. approval for stent that absorbs into body Reuters
11:22AM  FDA approves Abbott's Absorb bioresorbable stent, the only fully dissolving heart stent PR Newswire
Jun-30-16 09:09AM  Research Report Initiated on Select Medical Appliances and Equipment Equities
09:09AM  Research Report Initiated on Select Medical Appliances and Equipment Equities Company Spotlight
07:00AM  Healthcare: Stock Selection Increasingly Important Morningstar
07:00AM  Healthcare: Stock Selection Increasingly Important at Morningstar
Jun-29-16 02:42PM  Abbott Laboratories : ABT-US: Dividend Analysis : July 15th, 2016 (record date) : By the numbers : June 29, 2016
Jun-27-16 05:31PM  Mylan Launches Generic Version of Glaxo's Avodart in U.S.
03:15PM  ETFs with exposure to Abbott Laboratories : June 27, 2016
11:08AM  Whats the Verdict on Becton Dickinsons Strategic Portfolio Review?
09:31AM  Medtronic Rounds Out Heart-Failure Offerings With HeartWare Buy
12:42AM  Whats the Rationale behind Varians Imaging Components Spin-Off?
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and instrument used to identify infection-causing pathogens. The company's Nutritional Products segment provides pediatric and adult nutritional products, such as prepared infant and follow-on formulas. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company has strategic alliance with Fonterra. Abbott Laboratories was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ALLEN HUBERT LExecutive Vice PresidentJun 28Option Exercise20.753,40070,54591,857Jun 30 05:58 PM
ALLEN HUBERT LExecutive Vice PresidentJun 28Sale37.143,400126,27688,457Jun 30 05:58 PM
Watkin JaredSenior Vice PresidentJun 15Sale37.6355220,77046,562Jun 17 05:05 PM
YOOR BRIAN BSenior Vice President and CFOJun 01Sale39.4956522,31249,617Jun 03 05:10 PM
NATH DEEPAK S.Senior Vice PresidentApr 28Sale41.31532,18947,382Apr 29 05:01 PM
Contreras JaimeSenior Vice PresidentMar 31Sale41.7846219,3042,426Apr 01 05:01 PM
Ford Robert BExecutive Vice PresidentFeb 29Sale39.281,70667,02060,789Mar 02 07:32 PM
NATH DEEPAK S.Senior Vice PresidentFeb 29Sale39.2779331,14247,571Mar 02 07:30 PM
Fussell Stephen RExecutive Vice PresidentFeb 29Sale39.261,40255,044154,967Mar 02 07:28 PM
Contreras JaimeSenior Vice PresidentFeb 29Sale38.9410,617413,40947,667Mar 02 07:28 PM
Blaser Brian JExecutive Vice PresidentFeb 29Sale39.291,54360,626129,482Mar 02 07:12 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 29Sale39.291,54360,61888,457Mar 02 07:11 PM
ASHLEY RICHARD WExecutive Vice PresidentFeb 29Sale39.283,086121,221354,517Mar 02 07:10 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentFeb 29Sale39.2688134,58961,792Mar 02 07:02 PM
YOOR BRIAN BSenior Vice President and CFOFeb 29Sale39.1286533,84351,385Mar 02 07:01 PM
Mason Heather LExecutive Vice PresidentFeb 29Sale39.273,032119,05565,102Mar 02 06:49 PM
Funck Robert EVice President, ControllerFeb 29Sale39.301,33352,39385,019Mar 02 06:07 PM
Warmuth Michael JExecutive Vice PresidentFeb 29Sale38.849,399365,09355,011Mar 02 05:14 PM
Pavee Jean-YvesSenior Vice PresidentFeb 29Sale39.241,66565,32636,149Mar 02 05:09 PM
NATH DEEPAK S.Senior Vice PresidentFeb 22Sale39.0931912,47150,404Feb 23 05:44 PM
Watkin JaredSenior Vice PresidentFeb 22Sale39.0955421,65848,535Feb 23 05:38 PM
NATH DEEPAK S.Senior Vice PresidentFeb 16Sale37.131716,34934,941Feb 17 05:57 PM
WHITE MILES DChairman and CEODec 16Option Exercise21.22438,0009,294,0971,832,153Dec 18 05:01 PM
WHITE MILES DChairman and CEODec 16Sale46.00438,00020,149,9581,394,153Dec 18 05:01 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 28Sale39.6581532,31239,974Sep 29 05:36 PM
Fussell Stephen RExecutive Vice PresidentAug 18Sale50.4613,096660,854130,601Aug 20 05:18 PM
Fussell Stephen RExecutive Vice PresidentAug 11Option Exercise21.2241,500880,605172,101Aug 13 05:02 PM
Funck Robert EVice President, ControllerJul 29Option Exercise21.2226,000551,70497,448Jul 30 05:51 PM
Blaser Brian JExecutive Vice PresidentJul 28Sale50.9611,300575,904102,194Jul 30 05:52 PM